Medesis Pharma SA Cash Flow-to-Debt Ratio

Latest as of December 2020: 0.06x

Medesis Pharma SA cash flow-to-debt ratio. Medesis Pharma SA (ALMDP) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2020, meaning its operating cash flow of €185.83K could theoretically repay 0% of its total liabilities (€2.92 Million) in one year. See ALMDP financial flexibility score to measure the company's free cash flow as a share of total liabilities.

CF-to-Debt Ratio

0.06x
Operating CF / Total Liabilities

Operating Cash Flow

€185.83K
EUR

Total Liabilities

€2.92 Million
EUR

Data as of

Dec 2020
Most recent filing

Cash Flow-to-Debt Ratio of Medesis Pharma SA (2019–2020)

Cash flow-to-debt ratio of Medesis Pharma SA from 2019 to 2020. Historical debt coverage capacity for Medesis Pharma SA across 2 annual periods. Check cash flow reinvestment rate of Medesis Pharma SA to assess the company's total reinvestment commitment from operating cash flow.

Medesis Pharma SA Cash Flow-to-Debt Ratio by Year (2019–2020)

Medesis Pharma SA cash flow-to-debt ratio by year from 2019 to 2020. Year-by-year debt coverage analysis for Medesis Pharma SA. For the full cash flow conversion analysis, see ALMDP operating cash flow.

Year CF-to-Debt Ratio Operating CF (EUR) Total Liabilities YoY Change
2020 0.06x €185.83K €2.92 Million ▼ -40.3%
2019 0.11x €333.76K €3.13 Million —
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.